1. Home
  2. PODD vs TPR Comparison

PODD vs TPR Comparison

Compare PODD & TPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • TPR
  • Stock Information
  • Founded
  • PODD 2000
  • TPR 1941
  • Country
  • PODD United States
  • TPR United States
  • Employees
  • PODD N/A
  • TPR N/A
  • Industry
  • PODD Medical/Dental Instruments
  • TPR Apparel
  • Sector
  • PODD Health Care
  • TPR Consumer Discretionary
  • Exchange
  • PODD Nasdaq
  • TPR Nasdaq
  • Market Cap
  • PODD 22.1B
  • TPR 20.7B
  • IPO Year
  • PODD 2007
  • TPR 2000
  • Fundamental
  • Price
  • PODD $317.74
  • TPR $102.00
  • Analyst Decision
  • PODD Strong Buy
  • TPR Buy
  • Analyst Count
  • PODD 18
  • TPR 17
  • Target Price
  • PODD $341.00
  • TPR $116.71
  • AVG Volume (30 Days)
  • PODD 525.5K
  • TPR 2.8M
  • Earning Date
  • PODD 11-06-2025
  • TPR 11-06-2025
  • Dividend Yield
  • PODD N/A
  • TPR 1.62%
  • EPS Growth
  • PODD N/A
  • TPR N/A
  • EPS
  • PODD 3.45
  • TPR 1.25
  • Revenue
  • PODD $2,521,800,000.00
  • TPR $7,207,800,000.00
  • Revenue This Year
  • PODD $29.32
  • TPR $4.06
  • Revenue Next Year
  • PODD $18.37
  • TPR $4.48
  • P/E Ratio
  • PODD $93.81
  • TPR $79.00
  • Revenue Growth
  • PODD 27.11
  • TPR 8.14
  • 52 Week Low
  • PODD $230.05
  • TPR $49.29
  • 52 Week High
  • PODD $353.50
  • TPR $118.56
  • Technical
  • Relative Strength Index (RSI)
  • PODD 48.15
  • TPR 35.54
  • Support Level
  • PODD $290.16
  • TPR $93.00
  • Resistance Level
  • PODD $335.00
  • TPR $109.96
  • Average True Range (ATR)
  • PODD 10.46
  • TPR 3.68
  • MACD
  • PODD -0.11
  • TPR -1.66
  • Stochastic Oscillator
  • PODD 61.15
  • TPR 35.37

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About TPR Tapestry Inc.

Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounted for 80% of its revenue and well over 90% of its operating profit in fiscal 2025. Handbags accounted for 58% of the brand's fiscal 2025 revenue. Coach products are sold through more than 900 company-owned stores, e-commerce, and third-party stores in North America, Asia, and Europe. Tapestry also owns Kate Spade (17% of fiscal 2025 revenue), which operates about 170 stores and generated 52% of its sales from handbags in fiscal 2025. Kate Spade is known for its colorful patterns and graphics. Tapestry sold its smallest brand, luxury footwear maker Stuart Weitzman, to Caleres in August 2025.

Share on Social Networks: